Financials Braster S.A.

Equities

BRA

PLBRSTR00014

Biotechnology & Medical Research

Market Closed - Warsaw S.E. 11:55:54 2024-04-30 EDT 5-day change 1st Jan Change
0.58 PLN -.--% Intraday chart for Braster S.A. -.--% -.--%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 63.35 18.34 10.62 10.06 22.66 22.06
Enterprise Value (EV) 1 50.55 24.6 20.86 22.1 36.01 34.48
P/E ratio -2.55 x -0.93 x -0.68 x -0.63 x -3.39 x -5.18 x
Yield - - - - - -
Capitalization / Revenue 160 x 21.2 x 18.2 x 52.7 x 52 x 9.85 x
EV / Revenue 127 x 28.4 x 35.8 x 116 x 82.6 x 15.4 x
EV / EBITDA -2.21 x -1.38 x -1.74 x -4 x -14.7 x -31.7 x
EV / FCF -2.32 x -2.17 x -5.36 x -27.6 x -68.4 x -45.2 x
FCF Yield -43.1% -46.1% -18.7% -3.62% -1.46% -2.21%
Price to Book 1.3 x 0.63 x 0.51 x 1.27 x 12.8 x 35.1 x
Nbr of stocks (in thousands) 9,169 9,169 19,034 22,258 25,293 28,393
Reference price 2 6.910 2.000 0.5580 0.4520 0.8960 0.7770
Announcement Date 18-04-06 19-04-12 20-06-30 21-07-21 22-05-03 23-05-02
1PLN in Million2PLN
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 0.397 0.866 0.583 0.191 0.436 2.24
EBITDA 1 -22.82 -17.79 -11.96 -5.525 -2.456 -1.086
EBIT 1 -24.01 -18.71 -13.7 -7.275 -4.267 -2.53
Operating Margin -6,048.61% -2,160.05% -2,349.4% -3,808.9% -978.67% -112.95%
Earnings before Tax (EBT) 1 -25.04 -19.84 -15.37 -15.88 -6.69 -3.872
Net income 1 -24.89 -19.78 -15.54 -15.99 -6.69 -3.872
Net margin -6,270.03% -2,284.3% -2,665.01% -8,370.68% -1,534.4% -172.86%
EPS 2 -2.715 -2.160 -0.8163 -0.7183 -0.2645 -0.1500
Free Cash Flow 1 -21.79 -11.35 -3.89 -0.8008 -0.5264 -0.7631
FCF margin -5,489.64% -1,310.35% -667.22% -419.24% -120.73% -34.07%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 18-04-06 19-04-12 20-06-30 21-07-21 22-05-03 23-05-02
1PLN in Million2PLN
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 - 6.27 10.2 12 13.3 12.4
Net Cash position 1 12.8 - - - - -
Leverage (Debt/EBITDA) - -0.3523 x -0.8556 x -2.18 x -5.435 x -11.43 x
Free Cash Flow 1 -21.8 -11.3 -3.89 -0.8 -0.53 -0.76
ROE (net income / shareholders' equity) -59.5% -50.8% -62.4% -111% -138% -333%
ROA (Net income/ Total Assets) -21.7% -18.2% -16.6% -10.7% -8.95% -6.58%
Assets 1 114.8 108.4 93.83 149 74.77 58.81
Book Value Per Share 2 5.320 3.160 1.090 0.3600 0.0700 0.0200
Cash Flow per Share 2 2.740 0.5900 0.1200 0.0100 0 0
Capex 1 2 1.52 0.48 0.07 - -
Capex / Sales 504.03% 175.64% 82.5% 35.6% - -
Announcement Date 18-04-06 19-04-12 20-06-30 21-07-21 22-05-03 23-05-02
1PLN in Million2PLN
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. BRA Stock
  4. Financials Braster S.A.